IL1B and fatty liver disease: In our study, CEL significantly decreased both the liver inflammatory score and pro-inflammatory gene expression (Tnfa and Il1b) at the end of week 16, similar to that in various other studies with mouse models of fatty liver (Zhang et al., 2016; Li M. et al., 2022).